These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 26902792)

  • 1. Skin Oil Staining to Avoid Infusion Set Cannula Crimping: A Personal Observation.
    Bossi AC
    J Diabetes Sci Technol; 2016 Sep; 10(5):1201-2. PubMed ID: 26902792
    [No Abstract]   [Full Text] [Related]  

  • 2. Needle detachment from the Sure-T infusion set in two young children with diabetes mellitus (DM) treated with continuous subcutaneous insulin infusion (CSII) and unexplained hyperglycaemia.
    Massa G; Gys I; Eyndt AO; Wauben K; Vanoppen A
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):237-9. PubMed ID: 25153227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of vitamin E oil in primary herpes gingivostomatitis in an adult.
    Starasoler S; Haber GS
    N Y State Dent J; 1978 Nov; 44(9):382-3. PubMed ID: 283343
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of Intradermal and Subcutaneous Infusion Set Performance Under 24-Hour Basal and Bolus Conditions.
    McVey E; Keith S; Herr JK; Sutter D; Pettis RJ
    J Diabetes Sci Technol; 2015 Aug; 9(6):1282-91. PubMed ID: 26319228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies.
    Gibney M; Xue Z; Swinney M; Bialonczyk D; Hirsch L
    Diabetes Technol Ther; 2016 Mar; 18(3):136-43. PubMed ID: 26701357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilized human insulin prevents catheter occlusion during continuous subcutaneous insulin infusion.
    Walter HM; Timmler R; Mehnert H
    Diabetes Res; 1990 Feb; 13(2):75-7. PubMed ID: 2091873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rupture of needle during infusion with portable insulin pump in children.
    Wieliczko MC; Mallet E
    Diabetes Care; 1989 Jun; 12(6):440. PubMed ID: 2731465
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion.
    Patte C; Pleus S; Wiegel C; Schiltges G; Jendrike N; Haug C; Freckmann G
    Diabetes Technol Ther; 2013 Apr; 15(4):289-94. PubMed ID: 23427865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infusion sets. Tips for keeping your insulin pump cannula or needle in place.
    Neithercott T
    Diabetes Forecast; 2013 Jan; 66(1):56-9. PubMed ID: 23373087
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of continuous subcutaneous insulin infusion (CSII) on microvascular blood flow in diabetes mellitus.
    Tymms DJ; Tooke JE
    Int J Microcirc Clin Exp; 1988 Nov; 7(4):347-56. PubMed ID: 3220680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two case reports of retained steel insulin pump infusion set needles.
    Plager P; Murati MA; Moran A; Sunni M
    Pediatr Diabetes; 2016 Mar; 17(2):160-3. PubMed ID: 25683199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous insulin infusion is more effective than multiple daily insulin injections in preventing albumin excretion rate increase in Type 1 diabetic patients.
    Lepore G; Bruttomesso D; Bonomo M; Dodesini AR; Costa S; Meneghini E; Corsi A; Nosari I; Trevisan R
    Diabet Med; 2009 Jun; 26(6):602-8. PubMed ID: 19538235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes.
    Cescon M; DeSalvo DJ; Ly TT; Maahs DM; Messer LH; Buckingham BA; Doyle FJ; Dassau E
    J Diabetes Sci Technol; 2016 Nov; 10(6):1268-1276. PubMed ID: 27621142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetic ketoacidosis during insulin pump therapy].
    Walter H; Günther A; Timmler R; Mehnert H
    Dtsch Med Wochenschr; 1989 May; 114(18):706-8. PubMed ID: 2496965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trial of a topical preparation containing urea, sunflower oil, evening primrose oil, wheat germ oil and sodium pyruvate, in several hyperkeratotic skin conditions].
    Ferrando J
    Med Cutan Ibero Lat Am; 1986; 14(2):133-7. PubMed ID: 3528709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic education regarding type 1 diabetes (DM1)].
    Jansà M; Vidal M; Conget I; Giménez M; Esmatjes E; Yoldi C; Levy I
    Rev Enferm; 2007 Oct; 30(10):23-32. PubMed ID: 18274393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable continuous intravenous insulin infusion device. Restoration of flow after slow-down.
    Kernstine KH; Kryjeski SR; Wigness BD; Goldenberg FJ; Rohde TD; Dorman FD; Chute EP; Rupp WM; Buchwald H
    ASAIO Trans; 1986; 32(1):511-4. PubMed ID: 3778759
    [No Abstract]   [Full Text] [Related]  

  • 20. Significant time until catheter occlusion alerts in currently marketed insulin pumps at two basal rates.
    van Bon AC; Dragt D; DeVries JH
    Diabetes Technol Ther; 2012 May; 14(5):447-8. PubMed ID: 22548715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.